Abstract
L-3,4-dihydroxyphenylalanine (DOPA) is a neurotransmitter candidate. To map the DOPAergic system functionally, DOPA-induced c-Fos expression was detected under inhibition of central aromatic L-amino acid decarboxylase (AADC). In rats treated with a central AADC inhibitor, DOPA significantly increased the number of c-Fos-positive nuclei in the paraventricular nuclei (PVN) and the nucleus tractus solitarii (NTS), and showed a tendency to increase in the supraoptic nuclei (SON), but not in the striatum. On the other hand, DOPA with a peripheral AADC inhibitor elevated the level of c-Fos-positive nuclei in the four regions, suggesting that DOPA itself induces c-Fos expression in the SON, PVN and NTS. In rats treated with 6-hydroxydopamine (6-OHDA) to lesion the nigrostriatal dopamine (DA) pathway, DOPA significantly induced c-Fos expression in the four regions under the inhibition of peripheral AADC. However, under the inhibition of central AADC, DOPA did not significantly increase the number of c-Fos-positive nuclei in the four regions, suggesting that DOPA at least in part induces c-Fos expression through its conversion to DA. It was likely that the 6-OHDA lesion enhanced the response to DA, but attenuated that to DOPA itself. In...Continue Reading
References
Jan 2, 1989·European Journal of Pharmacology·G S RobertsonH A Robertson
Dec 4, 1989·Brain Research·H A RobertsonG S Robertson
Jun 1, 1987·Journal of Neurochemistry·N Mons, M Geffard
Jun 3, 1988·Science·S M SagarT Curran
Dec 19, 1988·Neuroscience Letters·H OkamuraM Geffard
Dec 19, 1988·Neuroscience Letters·K KitahamaM Geffard
Sep 1, 1986·British Journal of Pharmacology·Y GoshimaY Misu
Dec 1, 1984·Neurology·E MelamedM Globus
Sep 1, 1994·Neuroscience·J L YueY Misu
Apr 1, 1993·Trends in Pharmacological Sciences·Y Misu, Y Goshima
Apr 1, 1993·Experimental Neurology·D G ColeM DiFiglia
Aug 1, 1996·Progress in Neurobiology·Y MisuH Okamura
Jul 7, 1999·Neuroscience·T MiyamaeY Misu
Mar 10, 2000·Brain Research Bulletin·S A AicherD J Reis
Oct 13, 2000·Neuroscience·P SvenningssonP E Andren
Apr 20, 2001·Neuroscience·Y SugayaY Misu
Jul 10, 2002·Neuroscience Research·Kaori YamanashiYoshio Goshima
Feb 1, 2003·Pharmacology & Therapeutics·Yoshimi MisuYoshio Goshima
Aug 2, 2003·Neurochemistry International·S K LaiK K L Yung
Oct 24, 2003·Lancet Neurology·David S Goldstein
Citations
Jun 15, 2010·Neuroscience Research·Amal AlachkarOwen T Jones
Mar 27, 2012·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·L WangY Taché
Sep 19, 2006·European Journal of Pharmacology·Jun-ichi IzawaYoshio Goshima
Jul 16, 2008·Neuroscience Letters·Y MurotaY Goshima
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan
Oct 22, 2019·Frontiers in Pharmacology·Yoshio GoshimaAderemi Caleb Aladeokin